INCY

#505
Incyte Genomics Inc
101.27
+3.23%
Setor:
Base:
Moeda do lucro:
Faixa diária
101.27
101.27
Faixa anual
53.56
112.29
Mudança diária
+3.23%
Mudança mensal
-1.70%
Mudança em 6 meses
+19.86%
Mudança anual
+37.73%
Fechamento anterior
98.10
Open
101.27
Bid
Ask
Low
101.27
High
101.27
Volume
241
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization 19.77 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.41
Price to sales ratio
3.86
Dividends per share
—
Dividend yield %
—

Incyte Corporation

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

Notícias